Physician profile
William E Boshinski
NPI 1568412443
$855.18
in general payments reported to CMS, 2019-2025
11 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $26.54 · 2021: $22.75 · 2022: $14.69 · 2023: $77.52 · 2024: $400 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $249.52 | 2022-2025 | Precision 1, Total30, Precision7 |
| Bausch & Lomb Americas INC. | $139.88 | 2025 | Miebo, Xiidra, Infuse |
| Biotissue Holdings INC. | $125.00 | 2024 | |
| Topcon Healthcare, INC. | $117.81 | 2024 | |
| Shire North American Group INC | $69.19 | 2019 | |
| Genzyme Corporation | $60.35 | 2019 | |
| Coopervision INC. | $43.23 | 2019-2020 | |
| Astellas Pharma US INC | $15.90 | 2023 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.55 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.53 | 2021 | |
| Allergan, INC. | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Boshinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.